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Impaired mobility associated with an increased likelihood of death in children: a 
systematic review 
Sally Nissen, Edward Purssell, Karen Shaw, Cara Bailey, Nikolaos Efstathiou, 
Carolyn Dunford 
Abstract  
 
Improved identification of children with increased likelihood of death can support 
appropriate provision of integrated palliative care; this systematic review aims to 
consider immobility and the associated likelihood of death, in children with 
disabilities, living in high-income countries.  Two reviewers independently 
searched Medline, Embase, Cochrane Library, OpenGrey, Science Citation 
Index (1990 to 2016) for studies that reported hazard ratios (HR) and relative risk 
(RR) for likelihood of death related to impaired mobility. Nine papers were 
included. Three studies reported functioning using the Gross Motor Function 
Classification Scale (GMFCS); remaining studies reported measures of 
functioning unique to the study. The strongest single prognostic factor for 
likelihood of death was ‘lack of sitting ability at 24 months’, HR 44.4 (CI 6.1 to 
320.8) followed by GMFCS V HR 16.3 (CI5.6 to 47.2) and 11.4 (CI 3.76 to 35.57) 
and ‘not able to cruise by 24 months’ HR 14.4 (CI 3.5 to 59.2).  Immobility is 
associated with increased risk of dying over study periods, but different referent 
groups make clinical interpretation challenging; overall, quality of evidence is 
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moderate. The findings suggest that immobility can indicate suitability for 
integrated palliative care, for children with disabilities.   
 
Keywords: immobility, child health, palliative care, functioning, disability, GMFCS, 
systematic review   
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It is estimated in the World Health Report on Disability (2011), that in 2004, 
around 13 million children, under the age of 14 years, were living with severe 
disability (World Health Organization, 2011). The term ‘disability’ is now viewed 
as an umbrella term for impairments of body functioning (World Health 
Organization, 2012). Due to either increased survival, changes in disability 
definitions, or survey procedures, prevalence of disability in high-income 
countries is increasing (Halfon et al., 2012; Friebert and Williams, 2015).  
 
For some, there is a significant burden of illness (Read et al., 2012) and 
uncertainty, since health may be unpredictable and unstable (Horridge, 2015). 
Variations in definitions and prognostic criteria can hinder identification of children 
who are considered life limited (Friebert and Williams, 2015).  In the UK, children 
with ‘irreversible but non-progressive conditions causing severe disability, leading 
to susceptibility to health complications and likelihood of premature death’ are 
considered to be life limited (Together for Short Lives, 2013), and further 
delineation is available in a directory of life limiting conditions (Hain et al., 2013). 
However, while prevalence (or identification) of children with life limiting 
conditions is also increasing (Fraser et al., 2012), for children with severe 
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impairments of body functioning (World Health Organization, 2012) the focus is 
often on enhancing participation and improving quality of life (Rosenbaum, 2015) 
and consideration of likelihood of death is sometimes seen as incongruent with 
this focus, and may be given little consideration. While severe impairments are 
associated with death in childhood (Wolfe et al., 2014), prognostic uncertainty 
remains, and suitability for palliative care, therefore, uncertain.    
 
Children with recognised life limiting conditions, and their families, can benefit 
from palliative care, as an active approach to holistic care from diagnosis, 
regardless of whether treatment interventions are available; this approach 
involves giving support to the family as well as the child, and can be implemented 
even when resources are limited, such as by the team that know the child best, 
even when specialist palliative care teams are not available (World Health 
Organization, 2015). However, children with severe impairments are not always 
recognised as needing palliative care due to the uncertainty of prognosis, and the 
fact that many survive into adulthood.  Unfortunately, this puts some at risk of not 
receiving appropriate and timely palliative care, which, as for many chronic health 
conditions, can be of long term benefit (Siouta et al., 2016). 
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Palliative care in its different guises ranges from a philosophy of care to specialist 
services (Hain and Wallace, 2008), but is recognised under the United Nations 
human right to health. Palliative care for children with chronic health conditions, 
and their families, can help meet the increasing health needs of cumulative 
disabilities and decreasing quality of life (Dallara et al., 2014; Graham and 
Robinson, 2005; Viallard, 2014). However, this needs to be introduced early for 
maximising benefit such as improved symptom management, support for 
decision making, and reduced interventions at end of life (Hauer and Wolfe, 2014; 
Walter et al., 2013). For bereaved parents, lack of support at end-of-life, places 
them at increased risk of long-term psychological and physical morbidity 
(Rosenberg et al., 2012). 
 
While there is variability in local availability of palliative care services, and lack of 
consensus in the definition of integrated palliative care, it is generally accepted 
that palliative care is not a standalone intervention. An integrated approach, 
aimed at improving quality and quantity of life, is known to increase the quality of 
care and support health care professionals (Ewert et al., 2016). Even in the 
absence of focussed palliative care services, advance care planning for this 
population, is an important means of managing uncertainly and driving up 
standards in children’s palliative and end-of-life care  (Brook and Hain, 2008). 
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This dual planning concept, involves making multiple plans for care, and using 
the one that is most appropriate for the circumstances at the time (Villanueva et 
al., 2016). 
 
In trying to identify children with life limiting conditions, research has usually 
focused on either medical diagnoses (Hain et al., 2013), or impairments of body 
functioning (Strauss et al., 2000); however potentially both features could be used 
together to improve estimation of prognosis. For example, while spastic 
quadriplegic cerebral palsy [ICD 10 G80.0] and mixed cerebral palsy syndromes 
[ICD10 G80.0] are identified as life limiting (Hain et al., 2013), not all children with 
these diagnosis will die in childhood, and consideration of functional status 
(activity, performance and participation) is important (Bergstraesser et al., 2013). 
There may be specific impairments of functioning, routinely measured, within 
these diagnostic categories that may be useful in identifying children at increased 
likelihood of death. Attention to both diagnosis and impairments to functioning 
may therefore help health care professionals further define the population with 
an increased probability of death, and facilitate earlier interventions.  
 
Studies have reported increased probability of death to be associated with 
immobility (Ashwal, 2005; Cohen et al., 2008), lack of feeding skills, genetic 
 
7 
 
aetiology, hearing deficit (Cohen et al., 2008), inter-current illnesses with three or 
more co-existing disabilities (Decouflé and Autry, 2002), functional disability 
(Hutton, 1994), inability to recognise voices or speak intelligible words and 
incontinence (Katz, 2003). More recently, the presence of ventilatory airway 
support, pain/distress associated with feeding, and difficulty maintaining sitting 
position have been proposed as ‘vulnerability factors’ indicative of warranting 
palliative care (Harrop and Brombley, 2012) but the methods have not been 
reported in any detail. The focus of this review is mobility, a measurable aspect 
of body functioning allowing comparison; the International Classification of 
Functioning, Disability and Health (ICF) (World Health Organization, 2012) 
considers mobility to include a range of movements such as changing or 
maintaining a body position or location, carrying, moving or handling objects, 
walking or moving and using assorted forms of transportation. 
 
The impetus behind prognosis research in children with impairments, includes 
planning for future care needs, health insurance (Katz, 2003; Strauss et al., 2000; 
Christakis and Iwashyna, 1998) and clinical decision making (Hayden et al., 
2013). More recently, attempts have been made to further identify children with 
an increased risk of death for provision of palliative care services (Harrop and 
Edwards, 2013; Hain et al., 2013). Since access to palliative care is limited by an 
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uncertain prognosis, children with severe impairments may not have their needs 
fully met.    
 
Rational  
Knowledge of specific impairments of body functioning associated with increased 
likelihood of death in children can improve identification of those who may benefit 
from integrated palliative care. 
 
Objectives  
The primary objective for this review was to identify the likelihood of death 
associated with impaired mobility, in children with severe impairments, living in 
high income countries. This was done through a systematic review of studies 
reporting a point estimate of Hazard Ratio (HR) and Relative Risk (RR) for 
specific impairments of functioning related to mobility.  
 
 
Method  
 
Studies were retrieved using Medline, Embase, Cochrane Library, OpenGrey and 
Science Citation Index, from 1990 to 2016 and reference lists. Relevant studies 
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were located by combining search terms which included child, p?ediatric,  
disabilities, mortality, death, survival. For Medline search strategy see 
supplementary information. The last search was performed on 01/12/16. The 
reference lists of included studies, and the grey literature, were explored to locate 
potentially relevant studies for inclusion. No published protocol of the present 
review exists.  
 
All retrieved papers were reviewed to include studies using the following criteria 
1) observational cohort study with >50% follow up after 1980, published after 
1990 2) majority of participants were children (<18) for most of the study 3) 
children described as having disability/impairments 4) studies relating to mobility 
5) country of study defined by World Bank as high income, and, finally, 6) studies 
reporting a hazard ratio (HR) or relative risk (RR) for mortality. Studies of cancer, 
gestation, psychiatry, seizures, trauma, interventions, medicinal products, and 
the neonatal period were excluded, as were studies of prognostic factors 
unrelated to body functioning, such as biomarkers. As the focus of this review is 
prognostic factors, which are distinct from the actual cause of death, studies 
dealing with this alone, were also excluded.  
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All data were extracted onto piloted forms (SN) and then checked independently 
(EP).   The point estimates and associated confidence intervals of the hazard 
ratio (HR) and relative risk (RR) were abstracted for synthesis by two authors 
independently (SN, EP). Two authors (SN, EP) then independently assessed the 
quality of studies using the Quality in Prognosis Studies (QUIPS) tool (Hayden et 
al., 2013) which assesses quality in terms of study participation, attrition, 
prognostic factor and outcome measurement, confounding, statistical analysis 
and reporting, resulting in a judgment of high, moderate or low risk of bias. The 
forest plot was drawn in the R package ‘forestplot’. 
 
 
Results 
 
Nine studies met the inclusion criteria (Figure 1, supplementary information). 
Data was extracted for impairments of body functioning related to mobility; most 
studies reported multiple factors. Figure 2 presents the findings in a Forest Plot, 
with immobility described as per study. This shows an indication of the magnitude 
of risk associated with each impairment but they are not necessarily directly 
comparable. The majority of studies reported functioning assessed using non-
standardised measures; two studies reported the Gross Motor Function 
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Classification Scale (GMFCS) (Palisano et al., 2008) level V, (Westbom et al., 
2011; Touyama et al., 2013); one study reported GMFCS combining level IV and 
V. (Baird et al., 2011) 
 
The characteristics of included studies are displayed in Table 1. The risk of bias 
of included studies was judged using the QUIPS checklist. Of the nine papers 
included, four were judged to be at low risk of bias in all sections of QUIPS 
checklist (see supplementary information), the remaining studies had at least one 
section rated as moderate risk of bias.   The most common aspect causing risk 
of bias was statistical analysis. 
 
Seven papers were reported as retrospective cohort studies (Baird et al., 2011; 
Touyama et al., 2013; Hemming et al., 2005; Strauss et al., 1998a; Evans et al., 
1990; Nielsen et al., 2002; Strauss et al., 1998b), one as case control (Cohen et 
al., 2008) (with two comparison groups) and one retrospective study of 
prospectively collected data (initial recruitment for another study, reporting vital 
status at a later point) (Westbom et al., 2011). This study suggested the data 
were collected as part of a research project, the remaining studies used routinely 
collected clinical data.  
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Studies used existing datasets, with two using the Client Development Evaluation 
Report (CDER) (Strauss et al., 1998a; Strauss et al., 1998b), two using registers 
of cerebral palsy (Westbom et al., 2011; Nielsen et al., 2002) and the remaining 
five, using clinical records, were reported as retrospective cohort studies (Baird 
et al., 2011; Touyama et al., 2013; Hemming et al., 2005; Evans et al., 1990; 
Cohen et al., 2008).  Sample sizes ranged from 277 to 12,719 but were not 
consistently reported.  All but two studies reported children with cerebral palsy as 
their population, one reported children as having ‘developmental disabilities’ and 
one with traumatic brain injury. Two studies originated in the USA, three studies 
originated in the UK, and singular studies were identified from Japan, Denmark, 
Sweden and Israel.  Eight were published in English and one in Danish 
(translated by a native speaker). Three studies used the GMFCS (Palisano et al., 
2008), although this scale categorises functioning rather than measuring it. 
Otherwise the measurement of functioning was unique to each study (or as in the 
case of the CDER, a local measure forming part of the data collection). Aspects 
of impairment, as potential prognostic factors, are presented as described by the 
study.  In most cases the referent groups constituted those children who did not 
have the impairment or the degree of impairment differed, leading to a high 
degree of clinical heterogeneity.  
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Figure 2 shows that the singular factor associated with the highest ratio was ‘lack 
of sitting ability at 24 months’ with HR 44.4 (CI. 6.1 to 320.8) (Baird et al., 2011), 
however, sitting ability is defined as ‘getting to any sitting position from any lying 
position on the floor and then sitting without propping with either arm for 15 
seconds’. This equated to 56 out of 200 in the exposed group compared to 1 out 
of 132 children in the referent group.  Two studies reported HR for GMFCS level 
V, with comparable results: 16.3 (CI 5.6 to 47.2), constituting 29 out of 166 
children in the exposed group compared to 4 out of 413 in the referent group and 
11.4 (CI 3.76 to 35.57) which equated to 25 out of 102 children in the exposed 
group compared to 5 out of 605 in the referent group (Touyama et al., 2013; 
Westbom et al., 2011). One study combined GMFCS level IV and V with a 
reduced HR of 6.2 (CI 2.8 to 14) equating to 55 out of 176 children in the exposed 
group compared to 2 out of 160 (Baird et al., 2011). In contrast, seemingly less 
severe impairments such as ‘no functional hand use’ and ‘rolls/sits but cannot 
walk unaided’ (Strauss et al., 1998a) were associated with lower hazard ratios of 
less than 3.  
 
All studies reported a range of follow up times according to date of birth and end 
point of the study (Table 1) therefore it is not possible to make any meaningful 
judgments about the effect of length of follow up on the hazard.  
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Discussion  
 
As far as we are aware, this is the first systematic review examining the impact 
of immobility on likelihood of death in children with severe impairments. We have 
extracted hazard ratios, which give an instantaneous risk at any given point over 
a period of time, and relative risk, which gives cumulative risk over a period of 
time.  While only a small number of studies were identified, this review adds to 
the growing body of literature seeking to identify children most at risk of death, 
and who might benefit from palliative care. These findings suggest an association 
with increased likelihood of death, rather than prediction of death or imminent 
death, for which more data would be required. However, the findings have 
implications for practice, policy and research.  
 
The clear majority of studies focussed on cerebral palsy, often seen to be a static 
condition. However, children may, in reality, have an unpredictable illness 
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trajectory. The clinical signs and level of disability for CP, for example, may 
change over time due to the long-term existence of hypertonia, contractures and 
musculoskeletal deformity, bone density, and life expectancy may be influenced 
by the presence of scoliosis, seizures, cardiac or respiratory factors 
(Wimalasundera &  Stevenson, 2016). For the static conditions captured within 
this review, impairments to functioning are an early indicator of risk. 
 
Given the increased likelihood of death for children who are not able to sit or 
‘cruise’ at 24 months of age (‘cruising’ refers to walking while holding onto 
something, defined in the study as ‘along furniture or wall, even if placed in 
standing, for at least two steps sideways in either direction’) (Baird et al., 2011) 
and those in the GMFCS level V category, health care professionals should 
consider these as specific high risk factors for mortality.  Nevertheless, all 
reported impairments were associated with an increased risk.    
 
With regards to the assessment of functioning itself, its measurement was diverse 
and study specific. Gross motor function was assessed using the GMFCS, CDER 
or non-standardised measures based on clinical judgement. Notably, GMFCS 
category V is directly related to immobility, with consideration of head and truck 
control, but where this was not used, immobility was gauged in ways unique to 
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each study, which renders further statistical analysis problematic. Evans et al 
(1990) defined immobility as ‘confined to a wheelchair which they did not propel 
themselves’; Cohen et al. (2008) defined immobility as ‘no mobility’; Hemming et 
al. (2005) defined immobility as ‘unable to walk even with aids, uses a wheelchair 
or is bed ridden’.  Strauss et al. (1998a) uses ‘rolls/sits but cannot walk unaided’ 
and Strauss et al. (1998b) rates immobility by the lowest of five CDER items 
(rolling and sitting, hand use, arm use, ability to creep and crawl and ambulation). 
Nielsen et al. (2002) described immobility as ‘ingen gangfunktion’, translated into 
English as ‘no walking function’. The GMFCS is considered a gold standard for 
categorising gross motor function and classifies into 5 levels. A more detailed 
measurement of gross motor function, such as the GMFM (CanChild, 2015) a 66-
item scale, could potentially give more comprehensive information by measuring 
changes in functioning, but would require more resources.  This measure would 
also define immobility more specifically and includes ability to roll and head 
control. 
 
Hand use was categorised as no functional use as opposed to some functional 
use by Strauss (1998a), and by Baird et al. (2011) using a 4 point hand 
manipulation scale. For hand use, validated measures of functioning exist such 
as the Manual Ability Classification Scale (MACS) (Eliasson et al., 2006). For 
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more detailed assessment of hand and arm use, the QUEST  (DeMatteo et al., 
1993) or the Melbourne  (Randall et al., 2001) are available. 
 
The findings of this review suggest that immobility (however measured or 
categorised) is a potential prognostic factor. However, it is uncertain if this is 
specific to the populations studied, which is primarily children with cerebral palsy. 
The direct links between immobility and causes of death have not been examined 
in this review. Causes of death, such as respiratory infections (Sidebotham et al., 
2014; Rousseau et al., 2015) may be due to factors such as immune insufficiency, 
poor swallowing, and inability to cough or achieve full lung expansion.  This 
review only offers a reminder that children who are immobile are more at risk of 
death, and that palliative care provision should be considered.  Research is 
needed to determine the links between immobility and causes of death, as 
immobility is unlikely to be a single prognostic factor but comprise of multiple 
impairments, making it at best a broad surrogate for these.  
 
For consideration of likelihood of risk, accurate functional measurement is 
imperative, and we would recommend that the minimum level of functional 
assessment should include GMFCS and MACS with consideration given to the 
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more detailed assessments suggested above. With accuracy of functional 
measurement, changes in body functioning can also be monitored.  
 
In the context of this review, the overall quality of the body of evidence was 
defined using the GRADE definition that is the extent to which we can be 
confident that these results reflect the association between prognostic factors and 
death in the underlying population (Huguet et al., 2013). Generalisability of these 
results to diagnosis other than cerebral palsy is limited, given all but two studies 
were conducted in this population. More specifically, according to GRADE 
(Huguet et al., 2013) the quality of a body of evidence involves a number of 
aspects. Consideration of within-study risk of bias (methodological quality) was 
judged to be moderate; the directness of evidence was judged to have no serious 
limitations as the samples were similar to the population of interest, although not 
necessarily to the broader population of children requiring palliative care. 
Although no formal tests of heterogeneity were undertaken, it was clear that there 
was heterogeneity of patient populations and in some cases between outcomes.  
Furthermore many of the confidence intervals are very wide, suggesting 
imprecise estimates of the population parameter.  
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However many of the effect estimates were strong, exceeding the GRADE levels 
of >2 and >5 for upgrading evidence by one and two levels respectively (GRADE, 
2013). Given the existing limitations, the evidence would have been given an 
overall judgment of very low or low, had it not been for the high magnitude of 
effect associated with some results. Therefore, there is moderate quality 
evidence for GMFCS level V and immobility as being associated with an 
increased likelihood of death in children living in high income countries, and low 
quality evidence for head control and hand use. The small number of studies is 
of concern, this was due primarily to the requirement for HR or RR to be reported 
but we were unable to assess the risk of publication bias, which for prognosis 
research is a known issue (Huguet et al., 2013; Riley et al., 2014). 
 
It is important to consider these findings alongside other available information, 
such as diagnosis (Hain, 2013). Communication of risk of death can support the 
difficult news of a potentially life limiting condition (Bluebond-Langner et al., 2016) 
which needs to be carefully discussed and considered alongside the individual 
preferences of the child and family for information (Andrews et al., 2013; Maltoni 
et al., 2005), with particular acknowledgement of the uncertainty reflected in the 
wide confidence intervals found in this analysis. However, if these factors are to 
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be used to inform provision of palliative care, there needs to be some consensus 
relating to the level of hazard indicative of the need.  
 
Palliative care should be seen, not as an end-point, but as part of a broader health 
system.  For example palliative care can be combined with rehabilitation 
approaches to facilitate self-management and self-care (Tiberini and Richardson, 
2015), although this model is most commonly found in the adult literature 
(Oldervoll et al., 2011; Kelley et al., 2012). Palliative care as ‘active total care’ 
and rehabilitation are not, even for children, mutually exclusive. Integrating 
palliative care into existing service provision, tailored to the needs of the child and 
family, acknowledges the inherent uncertainty, while maximising the potential for 
health and wellbeing, alongside the risk that the child may deteriorate and die.  
 
More rigorous research using prospective observational studies in defined 
populations, with validated measures of functioning are needed if we are to 
advance identification of children with increased likelihood of death, improve 
identification of life limiting conditions, and thus improve access to palliative care. 
However, such studies are likely to be costly, difficult to conduct and not able to 
report their findings for many years. New guidelines for reporting prognosis 
studies of tumour markers now exists (McShane et al., 2005), but none yet related 
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to functioning. Because of these problems, researchers should collaborate to 
develop a consensus about how to make better use of existing data, including 
the validated measures of functioning commonly used by health care 
professionals, particularly therapists, in this population of children. 
 
Conclusions 
 
This systematic literature review suggests that GMFCS level V and overall 
immobility are associated with a significantly increased likelihood of death in 
children, with existing severe impairments, living in high income countries. 
GMFCS can therefore support clinical judgement about whether integrated 
palliative care may be appropriate, as it provides a categorisation of immobility. 
In order to confirm this finding, researchers and health care professionals 
collecting routine data should use validated measures of functioning.  
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